Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02450760
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
5FP![]() | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID | A,B | 1XE6 | 0.84 | ![]() |
5FE![]() | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID METHYL ESTER | A,B | 1XE5 | 0.83 | ![]() |
0AG![]() | N-(ethoxycarbonyl)-L-leucine | I,J | 1PSA | 0.74 | ![]() |
CLH![]() | 2-AMINO-6-[2-(2-OXO-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.73 | ![]() |
ATI![]() | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.75 | ![]() |
097![]() | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A,B | 3HY7 | 0.72 | ![]() |
097![]() | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A,B | 2JIH | 0.72 | ![]() |
097![]() | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A | 1R55 | 0.72 | ![]() |
76V![]() | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE | A | 2DCB | 0.74 | ![]() |
AMK![]() | (S)-4-AMINO-4-{(S)-1-[(S)-2-CARBAMOYL- 1-((S)-1-{(S)-[(1R,2R)-2-((S)-1- CARBOXY-ETHYLCARBAMOYL)-CYCLOPENTYL]- HYDROXY-METHYL}-3-METHYL-BUTYLCARBAMOYL)- ETHYLCARBAMOYL]-2-METHYL-PROPYLCARBAMOYL}- BUTYRIC ACID | A,B,C | 1YM4 | 0.7 | ![]() |
ABX![]() | 5-[1-(ACETYLAMINO)-3-METHYLBUTYL]- 4-(METHOXYCARBONYL)PROLINE | A | 1XOE | 0.72 | ![]() |
52A![]() | (2R,4R)-4-aminopyrrolidine-2,4- dicarboxylic acid | A,B | 2E4Y | 0.7 | ![]() |
ACV![]() | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.71 | ![]() |
ACV![]() | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.71 | ![]() |
ACV![]() | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.71 | ![]() |
ACV![]() | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.71 | ![]() |
59A![]() | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCINE | A | 2DC8 | 0.72 | ![]() |
074![]() | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.76 | ![]() |
75V![]() | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE | A | 2DCA | 0.74 | ![]() |
AN0![]() | N-ACETYL-L-NORVALINE | C,D,E,X,Y,Z | 2G7M | 0.7 | ![]() |
AN0![]() | N-ACETYL-L-NORVALINE | A | 1ZQ8 | 0.7 | ![]() |
042![]() | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-THREONYL-L-ISOLEUCINE | A | 2DC7 | 0.77 | ![]() |
2NC![]() | N-{(2S)-2-[(N-acetyl-L-threonyl- L-isoleucyl)amino]hexyl}-L-norleucyl- L-glutaminyl-L-argininamide | A,B | 3BVA | 0.71 | ![]() |
C6L![]() | N-hexanoyl-L-homoserine | A | 3DHA | 0.73 | ![]() |
C6L![]() | N-hexanoyl-L-homoserine | A | 3DHB | 0.73 | ![]() |
AHE![]() | 2-AMINO-4-[1-CARBOXYMETHYL-CARBAMOYL)- 2-HYDROXYMETHYLSULFANYL-ETHYLCARBAMOYL]- BUTYRIC ACID | A | 3BHM | 0.72 | ![]() |
AHE![]() | 2-AMINO-4-[1-CARBOXYMETHYL-CARBAMOYL)- 2-HYDROXYMETHYLSULFANYL-ETHYLCARBAMOYL]- BUTYRIC ACID | A,B | 1MC5 | 0.72 | ![]() |
CLG![]() | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.74 | ![]() |